AKS Khan Pharmaceuticals secures $12.5 million IFU investment
Deal News | Jan 22, 2025 | Investment Fund for Developing
The Investment Fund for Developing Countries (IFU) has committed USD 12.5 million to AKS Khan Pharmaceuticals (AKPL), a leading retail pharmacy chain in Bangladesh. This landmark investment aims to enhance access to world-class healthcare across the nation. The investment will facilitate the expansion of 50 new pharmacies and over 30 diagnostic centers, enabling AKPL to reach 8 million patients annually within five years. This strategic growth, focusing on outreach beyond Dhaka to underserved areas, is poised to improve the country's healthcare delivery significantly. The collaboration reflects Denmark's commitment to Bangladesh's socioeconomic development and its economic prospects. IFU has highlighted healthcare investment as pivotal to its strategy, advocating a future where quality healthcare is accessible to all, exemplifying its long-standing impact investment philosophy.
Sectors
- Healthcare
- Private Equity
Geography
- Bangladesh – The geographical focus of the article is Bangladesh, where the investment and expansion of healthcare facilities are taking place.
- Denmark – IFU, a Danish investment fund, is making the investment, reflecting Denmark's interest in the economic development of Bangladesh.
Industry
- Healthcare – The article discusses investments in the healthcare sector, specifically through pharmacies and diagnostic centers in Bangladesh.
- Private Equity – IFU's investment into AKS Khan Pharmaceuticals falls under private equity, aimed at expanding healthcare access and infrastructure in Bangladesh.
Financials
- USD 12.5 million – Investment amount committed by IFU to support AKS Khan Pharmaceuticals' expansion.
Participants
| Name | Role | Type | Description |
|---|---|---|---|
| AKS Khan Pharmaceuticals | Target Company | Company | A leading pharmacy chain in Bangladesh which aims to expand its services with the help of IFU's investment. |
| IFU (Investment Fund for Developing Countries) | Investor | Company | A Danish investment fund focusing on impactful investments, partnering with AKS Khan Pharmaceuticals to enhance healthcare services in Bangladesh. |
| Lars Bo Bertram | CEO of IFU | Person | Chief Executive Officer of IFU, underlining the importance of the investment in Bangladesh's healthcare sector. |
| Samanzar Khan | MD and Founder of AKPL | Person | Managing Director and Founder of AKS Khan Pharmaceuticals, discussing the company's vision for healthcare expansion. |
| AKS Khan Holdings | Partner | Company | Partner with IFU in the investment to support AKS Khan Pharmaceuticals' expansion in Bangladesh. |